• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

VRBCF:US

241.2500 USD 0.00000.00%

As of 20:10:00 ET on 03/06/2014.

Snapshot for Virbac SA (VRBCF)

Open: - Day's Range: - Volume: 10
Previous Close: 241.2500 52wk Range: 198.4500 - 241.2500 1-Yr Rtn: -

Stock Chart for VRBCF

No chart data available.
  • VRBCF:US 241.2500
  • 1D
  • 1M
  • 1Y
241.2500
Interactive VRBCF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for VRBCF

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 22.8300
Relative P/E vs. SPX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) 7.6480
Est. PEG Ratio -
Market Cap (M USD) 2,040.49
Shares Outstanding (M) 8.46
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.09%
Cash Dividend (EUR) 1.9000
Dividend Ex-Date 06/20/2014
5 Year Dividend Growth 7.41%
Next Earnings Announcement 08/29/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for VRBCF

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for VRBCF

Virbac SA manufactures antibiotics, worm medicines, and vaccines for veterinary use. The Company's products are distributed in the United States, Europe, Asia and South America.

Eric MareeChairman-Mgmt BoardMichel GaraudetChief Financial Officer
Pierre PagesChief Operating OfficerChristian KarstExec VP:Corporate Dev
More Company Profile & Key Executives for VRBCF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil